231 related articles for article (PubMed ID: 34798569)
1. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
Leuk Res; 2022 Jan; 112():106748. PubMed ID: 34798569
[TBL] [Abstract][Full Text] [Related]
2. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
Leuk Res; 2022 Feb; 113():106786. PubMed ID: 35063283
[TBL] [Abstract][Full Text] [Related]
3. Financial Hardship After Traumatic Injury: Risk Factors and Drivers of Out-of-Pocket Health Expenses.
O'Neill KM; Jean RA; Gross CP; Becher RD; Khera R; Elizondo JV; Nasir K
J Surg Res; 2020 Dec; 256():1-12. PubMed ID: 32663705
[TBL] [Abstract][Full Text] [Related]
4. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
[TBL] [Abstract][Full Text] [Related]
5. What do haematological cancer survivors want help with? A cross-sectional investigation of unmet supportive care needs.
Hall AE; Sanson-Fisher RW; Lynagh MC; Tzelepis F; D'Este C
BMC Res Notes; 2015 Jun; 8():221. PubMed ID: 26047620
[TBL] [Abstract][Full Text] [Related]
6. Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST).
Mejri N; Berrazega Y; Boujnah R; Rachdi H; El Benna H; Labidi S; Boussen H
Support Care Cancer; 2021 Jul; 29(7):4105-4111. PubMed ID: 33404807
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Relationship between Breast Reconstruction Subtype and Risk of Financial Toxicity: A Single-Institution Pilot Study.
Bailey CM; Asaad M; Boukovalas S; Lin YL; Kothamasu V; Kapur SK; Villa MT; Butler CE; Offodile AC
Plast Reconstr Surg; 2021 Jul; 148(1):1e-11e. PubMed ID: 34181599
[TBL] [Abstract][Full Text] [Related]
8. Insurance Coverage, Employment Status, and Financial Well-Being of Young Women Diagnosed with Breast Cancer.
Tangka FKL; Subramanian S; Jones M; Edwards P; Flanigan T; Kaganova Y; Smith KW; Thomas CC; Hawkins NA; Rodriguez J; Fairley T; Guy GP
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):616-624. PubMed ID: 32132129
[TBL] [Abstract][Full Text] [Related]
9. Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
Ezeife DA; Morganstein BJ; Lau S; Law JH; Le LW; Bredle J; Cella D; Doherty MK; Bradbury P; Liu G; Sacher A; Shepherd FA; Leighl NB
Clin Lung Cancer; 2019 Jul; 20(4):231-236. PubMed ID: 30797721
[TBL] [Abstract][Full Text] [Related]
10. Financial toxicity in gynecologic oncology.
Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
[TBL] [Abstract][Full Text] [Related]
11. Impact of Lung Cancer on Health-Related Quality of Life, Financial Toxicity, and Household Economics in Patients From the Public and the Private Healthcare Sector in Argentina.
Augustovski F; Tsou F; González L; Martín C; Vigo S; Gabay C; Alcaraz A; Argento F
Value Health Reg Issues; 2024 May; 41():94-99. PubMed ID: 38290167
[TBL] [Abstract][Full Text] [Related]
12. Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.
Durber K; Halkett GK; McMullen M; Nowak AK
Asia Pac J Clin Oncol; 2021 Aug; 17(4):377-387. PubMed ID: 33567158
[TBL] [Abstract][Full Text] [Related]
13. The Economic Impact on Australian Patients with Neuroendocrine Tumours.
Gordon LG; Elliott TM; Wakelin K; Leyden S; Leyden J; Michael M; Pavlakis N; Mumford J; Segelov E; Wyld DK
Patient; 2020 Jun; 13(3):363-373. PubMed ID: 32072460
[TBL] [Abstract][Full Text] [Related]
14. Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review.
Parker C; Berkovic D; Ayton D; Zomer E; Liew D; Wei A
Curr Oncol; 2022 May; 29(6):3807-3824. PubMed ID: 35735414
[TBL] [Abstract][Full Text] [Related]
15. Personal financial effects of multiple myeloma and its treatment.
Goodwin JA; Coleman EA; Sullivan E; Easley R; McNatt PK; Chowdhury N; Stewart CB
Cancer Nurs; 2013; 36(4):301-8. PubMed ID: 23047800
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Cost-Related Delays to Medical Care Among Lymphoma Patients: A 22-Year Analysis of a Nationally Representative Sample.
Jella TK; Cwalina TB; Treisman J; Hamadani M
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e619-e625. PubMed ID: 33785298
[TBL] [Abstract][Full Text] [Related]
17. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China.
Jing J; Feng R; Zhang X; Li M; Gao J
Breast Cancer Res Treat; 2020 Jun; 181(2):435-443. PubMed ID: 32306169
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
Huey RW; George GC; Phillips P; White R; Fu S; Janku F; Karp DD; Naing A; Piha-Paul S; Subbiah V; Tsimberidou AM; Pant S; Yap TA; Rodon J; Meric-Bernstam F; Shih YT; Hong DS
Oncologist; 2021 Jul; 26(7):588-596. PubMed ID: 33783054
[TBL] [Abstract][Full Text] [Related]
19. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
Mehlis K; Witte J; Surmann B; Kudlich M; Apostolidis L; Walther J; Jäger D; Greiner W; Winkler EC
BMC Cancer; 2020 Jun; 20(1):529. PubMed ID: 32503459
[TBL] [Abstract][Full Text] [Related]
20. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
